Publications by authors named "Meixiao Long"

Claim this Profile
R
Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.
Youyou Zhang, Mu Xu, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Meixiao Long

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss, Meixiao Long

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia.
Jessica Nunes, Rakeb Tafesse, Charlene Mao, Matthew Purcell, Xiaokui Mo, Meixiao Long

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy.
Po-Lan Su, Karthik Chakravarthy, Naoki Furuya, Jeremy Brownstein, Jianhua Yu, Meixiao Long

Mol Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD3 humanized mouse model unmasked unique features of T-cell responses to bispecific antibody treatment.
Lingling Wang, Vincent Leach, Natarajan Muthusamy, John Byrd, Meixiao Long

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement.
Meixiao Long, Alice S Mims, Zihai Li

Immunol Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUSD2 suppresses CD8 T cell antitumor immunity by targeting IL-2 receptor signaling.
Bao Zhao, Weipeng Gong, Anjun Ma, Jianwen Chen, Maria Velegraki, Meixiao Long

Nat Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity.
Chi-Ling Chiang, Eileen Y Hu, Lingqian Chang, Jadwiga Labanowska, Kevan Zapolnik, Meixiao Long

Cell Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients.
Kristin L Koenig, Thomas P Curley, Shylaja Mani, Ashleigh Keiter, Qiuhong Zhao, Meixiao Long

Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic illumination of druggable genes in cancer genomes.
Junjie Jiang, Jiao Yuan, Zhongyi Hu, Youyou Zhang, Tianli Zhang, Meixiao Long

Cell Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets.
Junjie Jiang, Jiao Yuan, Zhongyi Hu, Mu Xu, Youyou Zhang, Meixiao Long

Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets.
Zhongyi Hu, Jiao Yuan, Meixiao Long, Junjie Jiang, Youyou Zhang

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Eileen Y Hu, Priscilla Do, Swagata Goswami, Jessica Nunes, Chi-Ling Chiang, Meixiao Long

Blood Adv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Michael Ozga, James Blachly, Ann-Kathrin Eisfeld, Nicole Grieselhuber, Karilyn Larkin, Meixiao Long

Am J Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.
Nyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, Amy S Ruppert, Heather Breidenbach, Meixiao Long

Haematologica· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD33-Targeted Therapies: Beating the Disease or Beaten to Death?
Joseph E Maakaron, John Rogosheske, Meixiao Long, Veronika Bachanova, Alice S Mims

J Clin Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.
Adam S Kittai, David A Bond, Basem William, Ayman Saad, Sam Penza, Meixiao Long

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia.
Brynne Underwood, Qiuhong Zhao, Alison R Walker, Alice S Mims, Sumithira Vasu, Meixiao Long

Int J Hematol Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment.
Weiwei Shan, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yueying Wang, Meixiao Long

Cell Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia.
Caner Saygin, Nicole Grieselhuber, James Blachly, John C Byrd, Sumithira Vasu, Meixiao Long

Leuk Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Jiao Yuan, Kevin H Kensler, Zhongyi Hu, Youyou Zhang, Tianli Zhang, Meixiao Long

PLoS Genet· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of immune checkpoint molecule expression in mantle cell lymphoma.
Bonnie K Harrington, Esther Wheeler, Kasey Hornbuckle, Arwa Y Shana'ah, Youssef Youssef, Meixiao Long

Leuk Lymphoma· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.
Zhongyi Hu, Junzhi Zhou, Junjie Jiang, Jiao Yuan, Youyou Zhang, Meixiao Long

Nat Commun· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
Shuai Dong, Bonnie K Harrington, Eileen Y Hu, Joseph T Greene, Amy M Lehman, Meixiao Long

J Clin Invest· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γδ T cells for immunotherapy.
Meixiao Long

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis